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Research
AbstrACt
Objectives Sickness absence has been used as a central 
indicator of work disability, but has mainly been examined 
in single diseases, with limited follow-up time. This study 
identified the risk of long-term sickness absence (LTSA) of 
32 chronic disease groups in the first year after diagnosis 
and the subsequent years.
setting We identified chronic disease groups prevalent 
in the work force (26 physical and 6 mental conditions) 
requiring all levels of care (primary, secondary, tertiary), by 
national registers of diagnoses from all hospital visits and 
prescribed medicine in Denmark from 1994 to 2011.
Participants A general population sample within the 
working age range (18–59 years) was drawn by Statistics 
Denmark. Participants not working before and during 
the follow-up period were excluded. A total of 102 746 
participants were included.
Primary and secondary outcome measures HRs of 
transitions from work to LTSA of each of the chronic 
conditions were estimated in Cox proportional hazards 
models for repeated events—distinguishing between 
risk within the first (<1 year) and subsequent years of 
diagnosis (≥1 year) and an HR ratio (HRR): HR ≥1 year 
divided by HR <1 year.
results Almost all the conditions were associated with 
significantly increased risks of LTSA over time. The risks 
were generally more increased in men than in women. 
Three main patterns of LTSA were identified across 
diseases: strong decreases of LTSA from the first to 
subsequent years (eg, stroke in men <1 year: HR=7.55, 
95% CI 6.45 to 8.85; ≥1 year HR=1.43, 95% CI 1.20 to 
1.74; HRR=0.23). Moderate or small decreases in LTSA 
(HRR between 0.46 and 0.76). No changes (HRR between 
0.92 and 0.95) or increases in elevated risks of LTSA over 
time (HRR between 1.02 and 1.16).
Conclusions The 32 chronic diseases were associated 
with three different risk patterns of LTSA over time. These 
patterns implicate different strategies for managing work 
disability over time.
IntrOduCtIOn 
The collective burden of mortality and 
disability from chronic non-communicable 
conditions are increasing around the world.1 2 
Chronic conditions such as musculoskeletal 
and psychological disorders, cardiovascular 
disease, cancers, diabetes and chronic lung 
diseases are among the most common causes 
of lifelong disability.2 Although the growing 
number of individuals with chronic condi-
tions threatens work force productivity,3–5 
research addressing the work-related conse-
quences of the chronic disease burden is 
scarce, making it difficult to predict and 
manage implications. 
Most high-income countries have an ageing 
work force. To retain workers, many coun-
tries have increased the official retirement 
age resulting in an even larger proportion of 
elderly in the work force.6 7 Studies suggest 
that between 33% and 50% of workers have 
at least one chronic disease increasing to 
66% of workers between 55 and 64 years.5 8 
This impacts the risks of long-term sickness 
absence (LTSA), unemployment and early 
retirement9 10 and threatens the financial 
strengths and limitations of this study
 ► This study provides a new framework for identifying 
different risks patterns of long-term sickness ab-
sence over time.
 ► This method allows identification of the short-term 
and long-term consequences associated with 36 
different chronic diseases.
 ► Additional strengths were validity of diagnosis and 
the availability of data from all levels of care.
 ► Among the limitations, we did not evaluate the im-
pact of comorbidity, which is an important risk factor 
for work disability.
 ► When comparing the results with  other labour 
market systems, contextual factors need to be 
considered.
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security, identity and well-being of individuals experi-
encing chronic disabilities.11
LTSA have been used as a central indicator of work 
disability.12 However, few studies have compared risks of 
LTSA across several chronic conditions. Results from four 
studies indicated that anxiety and depression were associ-
ated with the highest risks of LTSA.13–16 The studies showed 
mixed results regarding the impact of chronic physical 
conditions on LTSA, probably reflecting the application 
of different diseases, classifications of diseases, outcome 
measurements and limited follow-up time.
Studies of inflammatory rheumatic and thyroid diseases 
found that the first year of diagnosis was associated with 
higher risks of LTSA than the subsequent years, presum-
ably due to a stabilisation of the condition.17 18 A longitu-
dinal study including different chronic diseases is needed 
to outline the risks of LTSA associated with different 
chronic conditions over time. The Danish registers of 
health and social reimbursements provide a unique 
opportunity to examine work disability associated with 
various chronic conditions.19
This study aimed to identify the risk of LTSA of 32 major 
chronic disease groups in the first year after diagnosis and 
the subsequent years.
MethOds
Population
The study used a general population sample (n=137 267) 
drawn by Statistics Denmark as a comparison group in 
a previous study on rheumatoid arthritis.17 Participants 
were of working age (18–59 years) with oversampling 
of women and participants in the 40–59 age range. We 
excluded 34 521 individuals according to the following 
criteria: missing values on key variables included in the 
analyses (n=22 066); died prior to study start or were not 
in the 20–59 years interval at any time during follow-up 
(n=1315); received disability pension or similar compen-
sation for reduced work ability prior to study start 
(n=8113); not employed before or during the follow-up 
period (n=3027). The final sample included 102 746 
individuals.
Included chronic conditions
An interdisciplinary group (the authors) with expertise 
in internal medicine, occupational health and psychi-
atry, reviewed all the diseases in the WHO’s Interna-
tional Classification of Diseases-10th edition (ICD-10)20 
and included or excluded conditions according to the 
following criteria:
 ► We included conditions that were chronic. Phys-
ical conditions were defined as chronic if biological 
processes impacted specific body structures, organs or 
functions, involving long duration usually requiring 
life-long treatment or monitoring.21 Mental condi-
tions had to be moderate or severe, which implicated 
intense treatment or monitoring for at least 2 years 
(eg, bipolar disorder or schizophrenia) or recurrent 
conditions (eg, episodic depression). We excluded 
conditions unlikely to be associated with considerable 
work disability (eg, food allergies).
 ► The conditions had to be prevalent in the working 
population (age 20–59 years).
 ► We excluded conditions incurring handicaps that 
made it difficult to enter or re-enter the labour market 
on normal employment terms. These concerned 
mainly congenital conditions (‘malformation’), 
conditions diagnosed in childhood or early adulthood 
(eg, mental retardation) and conditions or injuries 
that incurred acute death or sudden and permanent 
exit from the labour market (eg, severe brain injury).
We mostly grouped the chronic conditions according 
to the organ system involved (eg, diseases of the ear). 
A few conditions were better suited in another disease 
group (eg, sarcoidosis was grouped with inflammatory 
rheumatic diseases). Chronic pain has proven a good 
predictor of work disability22 and was therefore evaluated 
as an independent disease group in two ways: as a single 
condition (ie, not registered with any other chronic 
condition) or as a condition regardless of any other regis-
tered comorbid conditions (ie, chronic pain with other 
possible co-existent chronic conditions). Anxiety and 
affective disorders often overlap and treatment often 
implicates the same prescribed medicine. To reduce risk 
of misclassification we merged anxiety and affective disor-
ders into one disease group. The final list included 26 
chronic physical and 6 mental conditions (table 1).
data sources
In Denmark, information on health, demography, socio-
economy and social reimbursements are registered in 
national databases of high quality.19 All Danish citizens 
are assigned a unique personal identification number at 
birth, administrated by the Central Population Register 
(CPR), which we used to link data from different registers.
Ethical approval is not required for register studies 
in Denmark, but we followed standard guidelines as 
described in the Declaration of Helsinki. The study was 
registered and approved by the Danish Data Protection 
Agency, which is required by Danish law (identification 
number: 2015-41-3828) and allowed access to databases 
hosted at Statistics Denmark.
Chronic conditions
The 32 chronic conditions were identified by ICD diag-
noses in The Danish National Patient Registry (NPR)23 
and The Danish Psychiatric Central Research Register 
(PCRR).24 From NPR and PCRR we identified date and 
every ICD diagnosis registered for the study participants 
in the study period 1994–2011. Because Danish hospitals 
must report all inpatient and outpatient visits to NPR and 
PCRR, the validity is high and risk of misclassification 
low.23
To identify conditions treated in the primary sector by 
general practitioners, we also used the Danish National 
Prescription Registry (PRESCRIBE).25 PRESCRIBE holds 
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Table 1 Overview of ICD-10 codes and ATC codes of included chronic conditions
Chronic disease groups ICD-10 codes ATC codes
Physical conditions (abbreviated)
  Chronic infection (Infec) A52; B18; B20-24 J05AB04; J05AE; J05AF; J05AG; J05AR; J05A×07
  Cancer (Cancer) C00-C26; C30-C34; C37-41; 
C43; C45-58; C60-C85; C88; 
C90-97; D45-47
  Benign haematologic diseases 
including anaemia (Haemo)
D50-D53; D55-58; D66-68; 
D69.1; D69.3; D81-84; D89
B03XA
  Diseases of the thyroid gland 
(Thyroid)
E00-03; E05-07; E89.0 H03AA01; H03BA02; H03BB01; H03BB02
  Diabetes (Diabetes) E10.1-10.9; E11.0-11.9; E12-14 A10A; A10B; A10BA02
  Other endocrine diseases and 
malnutrition (Endo)
E20-27; E31-32; E34-35; E40-
46; E50-64
A09AA
  Obesity (Obesity) E65-66 A08AA03; A08AB01
  Neurological diseases (Neuro) G10-14; G20-26; G30-32; G35-
37; G40-41; G43-46; G60-64; 
G70-73; G80; 83; G90-99
N02C; N03AF; N03AX; N04A; N04B; N07CA03
  Paraplegia and hemiplegia 
(ParaHemi)
G81-82
  Eye diseases (Eyes) H20-22; H25-28; H30-36; H40; 
H06.2; H54; Q11-15
  Ear diseases (Ears) H80; H90-91; H93.1; Q16
  Hypertension (Hyperten) I10-I13; I15 C02CA; C07; C08; C09
  Ischaemic heart disease and heart 
failure (Heart)
I20-25; I42-43; I50 B01AC04; C01AA; C01D;
  Caridiac arrhythmia and valve 
disease (Arrhythm)
I05-09; I34-36; I44-49 C01BC; C01BD
  Stroke (Stroke) I60-69
  Vascular disease (Vascular) I26-28; I70-74; I77; I79
  Chronic pulmonary disease 
including asthma (Pulmonary)
E84; J41-47; J60-67; J68.4; 
J70.1; J70.3; J84.1; J84.8–9; 
J96
R03; VO3AN01
  Inflammatory bowel disease 
(Bowel)
K50-52; K57 A07EA; A07EC02; A07EC03; A07EC04
  Diseases of the liver (Liver) I85; I86.4; I98.2; K70; K71.3-9; 
K72-74; K75.3; K75.4; K76; K86
  Diseases of the skin (Skin) L23-27; L40-1; L43; L45; L93-
95; L97
D05; D07AB; D07AC; D07AD; D07BC; D07CC; D07X; 
D11AX
  Inflammatory rheumatic disease 
(Inflarheum)
D86; M02-3; M05-10; M14; 
M30-32; M34-36; M45-49; 
M72.6
A07EC01; L04AA13; M01CB01; M01CB03; M04AA01; 
M04AB; M04AC
  Degenerative rheumatic diseases 
and osteoarthritis (Osteoarthritis)
M15-19; M20-21; M23-25; M40-
43; M50-51; M54.3-54.5; M75; 
M79.7; M84.1; M86.3-86.5; 
M87-88; M90.0; M95
M01AX
  Osteoporosis (Osteoporosis) M80-85 G03XC01; H05AA02; H05AA03; M05BA
  Chronic pain (Pain) M01A; N02AA; N02AB; N02AC01; N0AC03;
N0AC04; N02A×1; N02A×2; N02A×3; N02A×5; 
N02A×6; N02A×52; N02B
  Chronic pain* (Pain*) M01A; N02AA; N02AB; N02AC01; N0AC03;
N0AC04; N02A×1; N02A×2; N02A×3; N02A×5; 
N02A×6; N02A×52; N02B
Continued
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information on all prescribed medicine in Denmark clas-
sified according to the Anatomical Therapeutic Chem-
ical (ATC) coding system. The ATC allows identification 
of those individuals with chronic conditions that never 
receive hospital treatment or get admitted to a hospital. 
The authors, including three medical doctors (MLH, 
JBB, TW), identified those ATC codes represented drugs 
as a unique treatment for the specific condition. ATC 
codes that were used to treat multiple conditions were 
excluded. Conditions were identified via ATC records 
only if the prescriptions had been redeemed at least five 
times during the study period.
Date of diagnosis was obtained from the data source 
with the earliest date of diagnosis/prescription. From 
records of ATC codes, dates for redemption and pack 
size, we were able to identify 20 of the 32 conditions. 
Table 1 presents all the ICD-10 diagnosis and ATC codes 
for each disease group.
Long-term sickness absence
The DREAM register (Danish Register-based Evaluation 
of Marginalization) covers all residents in Denmark, who 
have received social transfer payments in any given week 
since 1991.26 During the study period, Danish citizens were 
able to receive sickness benefits for a maximum of 52 weeks 
during a period of 2 years if they were unable to work due 
to illness or disability. In Denmark, from week 1 in 1994 
to April 1 2007 employers were reimbursed by the munic-
ipality after a minimum of 2 weeks and after 2 June 2008 
after a minimum of 3 weeks, that is, registered in DREAM. 
Reimbursements are registered in weeks. To reduce risk of 
misclassification, we classified the participants with LTSA if 
they received sickness absence benefits for a period of at 
least 4 consecutive weeks from week 1 in 1994 until week 30 
in 2011. Participants re-entered the risk group, when they 
returned to work after LTSA.
Covariates
Age and sex were identified via the CPR register and 
information on education, job type, immigrant and 
marital status was obtained from the Integrated Database 
for Labour Market Research, administrated by Statistics 
Denmark since 1980.27 28 Calendar year was also included 
as a covariate.
Statistical analysis
HRs for the transition from work to LTSA were esti-
mated by Cox proportional hazard models, in separate 
analyses for each of the 32 chronic conditions. The HR 
represented the risk of LTSA associated with each of the 
chronic conditions compared with not having the specific 
chronic condition (ie, individuals with other comorbidi-
ties were not excluded).
We used a multistate model accounting for recurrent 
episodes of LTSA: work and LTSA were treated as transient 
states in which the participants could re-enter these states.29 
Individuals were censored at the end of the study period, or 
before if they received disability pension, emigrated, died 
or turned 60 years. Participants who were unemployed, 
students or on maternity leave were temporarily excluded 
until they returned to the work state.
All variables were treated as time dependent, except 
immigrant status which was included as a time independent 
variable. The underlying time axis for the analysis was age.
Chronic disease groups ICD-10 codes ATC codes
  Diseases of the kidney (Kidney) E85; N03-5; N07-8; N11; N13.0-
13.3; N14; N16-19; N25-26; 
N30.1; N30.4; N31; N32.1-32.2; 
N36.0; N41.1
  Gynaecological diseases 
(Gynaecol)
N71.1; N73.1; N80
Mental conditions (abbreviated)
  Dementia (Dementia) F00-04; F06-7; F09; G30; G31.1 N06D
  Substance abuse (Abuse) F10.1-2; F10.8-9; F11.1; F11.5; 
F11.7-9; F12.1-2; F12.7-9; 
F13.1-2; F13.7-9; F14.1-2; 
F14.7-9; F15.1-2; F15.7-9; 
F16.1-2; F16.7-9; F18.2; F18.6-
8; F19.1-2; F19.6-7
N07BB01; N07BB04; N07BC01; N07BC02; N07BC51
  Schizophrenia (Schizo) F20-22; F25; F29
  Depression and anxiety (Anxdep) F31; F33-34; F40-42; F43.1; 
F44-45
N05AN; N05BB; N05BE; N06A
  Eating disorders (Eating) F50
  Personality disorders (Personality) F60-63; F68-69
*Chronic pain classification only if no other chronic comorbidities.
 ATC, Anatomic Therapeutic Chemical Classification System; ICD-10, International Classification of Diseases-10th edition. 
Table 1 Continued 
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Analyses were performed separately for men and 
women and for the first and for the subsequent year of 
diagnosis. Significance level was p<0.05.
The HR values were adjusted for immigrant status, 
highest attained education, marital status, calendar year 
and job type.
To provide an overview of the similarities and differ-
ences of HR across the conditions, we categorised the 
reporting of the results according to four levels: extremely 
elevated (HR ≥4.0), highly elevated (4.0 ˂ HR ≥2.5), 
moderately elevated (2.5 ˂ HR ≥1.5) and mildly elevated 
(1.5 ˂ HR >1.1).
To be able to evaluate how the HR of each condition 
changed over time we also estimated an HR ratio (HRR) 
by dividing HR of the subsequent years with the first 
year. We categorised according to five levels: extremely 
decrease (HRR ≤0.25), strongly decrease (0.25˃ 
HRR ≤0.40), moderately decreased (0.40 ˃ HRR ≤0.67), 
mildly decreased (0.67 ˃ HRR ≤0.91), no change or 
increase (>0.91 HRR>1.00).
All statistical analyses were performed in SAS V.9.2.
Patient and public involvement
This study was a register study and patients or the public 
were not involved. However, once the results have been 
published in a scientific journal the reference and a 
summary of the main findings of the study will be publicly 
available on the National Research Center of The Working 
Environment website.
results
The characteristics of the study cohort are presented 
in table 2. Because of the sampling strategy, women 
aged 40–59 years constituted the largest group (table 2).
The number and percentage of men and women with 
different chronic conditions increased from study entry 
to exit during the 17 years of follow-up (table 3).
The number of events (incidence of LTSA), person-
years and incidence rates (incidence of LTSA per 1000 
person-years) of each of the chronic conditions within the 
first year of diagnosis and subsequent years are provided 
in online supplementary web appendix 1.
hr in the first year after diagnosis
Except for some conditions with few events (chronic 
infection and thyroid diseases in men; eating disorders, 
dementia and chronic infection in women), all the other 
chronic conditions had statistically significant increased 
risk of LTSA within the first year of diagnosis (table 4 and 
online supplementary web appendices 1 and 2).
Women and men with cancer or stroke had extremely 
elevated risk of LTSA (HR 4.75–7.55), as had men with 
heart disease (HR=4.55). Women with heart disease had 
highly elevated risk (HR=2.60).
For many conditions (inflammatory rheumatic diseases, 
osteoarthritis, chronic pain, kidney diseases, substance 
abuse, anxiety and depression and personality disorder), 
risk of LTSA was highly elevated for both men and women 
(HR 2.58–3.99). Other conditions had stronger risk for 
men than for women: benign haematologic diseases, 
other endocrine diseases and malnutrition, neurological 
diseases, ischaemic heart disease, cardiac arrhythmia and 
valve disease, vascular disease and osteoporosis. Accord-
ingly, more conditions were associated with moderately 
elevated HR within the first year of diagnosis in women 
than men (table 4).
hr in the subsequent years after diagnosis
The HR of LTSA was significantly elevated for almost all 
conditions in the subsequent years of diagnosis (except for 
women with infection and men with benign haematologic 
disease or thyroid disease). However, none of the condi-
tions was associated with extremely or highly elevated HR. 
For both men and women, moderately elevated LTSA 
risk was seen for: obesity, neurological disease, ischaemic 
heart disease, pulmonary disease, liver disease, inflamma-
tory rheumatic disease, degenerative rheumatic disease, 
chronic pain, substance abuse, anxiety and depression. 
Again, many conditions seemed to carry stronger risk for 
men than for women: diabetes, eye disease, hypertension, 
cardiac arrhythmia and valve disease, vascular disease, 
inflammatory bowel disease, osteoporosis, kidney disease.
Changes in hr between the first and subsequent years
Table 4 illustrates the overall tendency: the HR of LTSA 
of each chronic condition was more elevated in the first 
than in subsequent years.
The decrease in LTSA from the first to the subsequent 
years was extreme in cancer (for both men and women) 
and in stroke for men (HR ratios 0.19–0.23; table 4) 
and strong in paraplegia and hemiplegia and stroke for 
women and ischaemic heart disease and heart failure for 
men (HR ratios 0.29–0.37).
In many diseases, the HR of LTSA decreased moder-
ately from the first to the subsequent years (HR ratios 
0.46 to 0.66, table 4). A mild decrease in risk of LTSA 
was observed in both men and women with hypertension, 
inflammatory bowel disease, liver disease and chronic 
pain (HR ratios 0.71–0.85), women with thyroid diseases, 
obesity, diseases of the ear, osteoporosis, depression/
anxiety, diabetes, chronic pulmonary disease and skin 
diseases (HR ratios 0.70–0.95) and in men with chronic 
pulmonary disease or skin disease (HR ratio=0.71–0.76).
No change was noted in chronic pulmonary diseases 
including asthma, diabetes and diseases of the skin for 
women (HR ratios 0.92–0.95). The risk of LTSA increased 
slightly in men with obesity (HR ratio=1.02) or diabetes 
(HR ratio=1.16).
dIsCussIOn
For both men and women, almost all the 32 mental 
and physical chronic conditions were associated with 
significantly increased risks of LTSA. The risks remained 
elevated throughout the study period, but the highest 
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risks of LTSA were seen in the first year after diagnosis 
(except for men with diabetes or obesity). Overall, the 
chronic conditions were associated with higher risks of 
LTSA in men than in women.
By contrast to previous studies,13–16 we were able to 
identify at least three patterns of LTSA characterising the 
different chronic conditions over time:
1. Conditions with an extreme or strong decrease in HR 
from the first to subsequent years of diagnosis (HR 
ratio between 0.23 and 0.29; cancer and stroke in 
men and women, paraplegia and hemiplegia in wom-
en and ischaemic heart disease and heart failure in 
men). These conditions had extremely or highly ele-
vated HR of LTSA in the first year of diagnosis (HR 
between 4.75 and 7.55) presumably reflecting that the 
conditions involve treatments (eg, surgery, chemother-
apy, neurorehabilitation) that required long-term ab-
sence from work in the first year. Part of the extreme 
or strong decrease in LTSA may reflect a permanent 
exit from the labour market of the sickest individuals 
Table 2 Overview of number and percentage of demographics variables at start of follow-up (entry) and end of follow-up (exit)
Variables
Women (n=75 319) Men (n=27 427)
Entry Exit Entry Exit
n (%) n (%) n (%) n (%)
Age (years)
  20–29 14 540 (19.3) 2165 (2.9) 3303 (12.0) 434 (1.6)
  30–39 16 648 (22.1) 6851 (9.1) 5656 (20.6) 1531 (5.6)
  40–49 23 064 (30.6) 15 028 (20.0) 9189 (33.5) 4346 (15.8)
  50–59 21 067 (28.0) 51 275 (68.0) 9279 (33.7) 21 116 (77.0)
Highest obtained education
  Vocational education 21 863 (29.0) 24 817 (32.9) 9949 (36.3) 10 564 (38.5)
  Primary school/high school 30 930 (41.1) 26 445 (35.1) 9086 (33.1) 882 (32.2)
  Short or medium long education 13 090 (17.4) 16 580 (22.0) 3897 (14.2) 3897 (16.6)
  Long education 2238 (3.0) 3731 (5.0) 1609 (5.9) 1609 (7.2)
  Missing 7189 (9.5) 3764 (5.0) 2886 (10.5) 1505 (5.5)
Job type
  Managers 2603 (3.5) 2044 (2.7) 3059 (11.2) 2426 (8.9)
  Highest level of knowledge work 7190 (9.6) 8947 (11.9) 3523 (12.8) 3826 (14.0)
  Medium level of knowledge work 11 987 (15.8) 15 323 (20.3) 2959 (10.8) 3619 (13.2)
  Clerical support work 13 235 (17.6) 12 045 (16.0) 1278 (4.7) 1259 (5.6)
  Service and sales work 15 094 (20.0) 15 782 (21.0) 1449 (5.3) 1785 (6.5)
  Agricultural, forestry and fishery 339 (0.5) 295 (0.4) 1031 (3.8) 907 (3.2)
  Craft and related trades 1100 (1.5) 1014 (1.3) 4911 (17.9) 4650 (17.0)
  Operators, installation, transport 3400 (4.5) 2980 (4.0) 2977 (10.7) 3326 (12.1)
  Other types of manual labour 9518 (12.6) 10 483 (13.9) 3453 (12.6) 4266 (15.5)
  Missing 10 853 (14.4) 6406 (8.5) 2787 (10.2) 1363 (5.0)
Marital status
  Married/cohabitant 54 030 (71.7) 56 026 (74.4) 19 684 (71.8) 20 646 (75.3)
  Single 16 164 (21.5) 18 349 (24.4) 5759 (21.0) 6332 (23.1)
  Missing 5156 (6.8) 944 (1.2) 1984 (7.2) 449 (1.6)
Immigration status
  Danish born 64 498 (85.6) 64 498 (85.6) 22 416 (81.7) 23 782 (82.6)
  Descendants 168 (0.2) 168 (0.2) 50 (0.2) 50 (0.2)
  Immigrant 10 653 (14.2) 10 653 (14.2) 4959 (18.1) 4959 (18.2)
Calendar years
  1994–1999 69 203 (91.9) 33 098 (43.9) 25 558 (93.2) 14 370 (52.4)
  2000–2005 4412 (5.9) 17 (22.6) 1356 (4.9) 5884 (21.5)
  2006–2011 1704 (2.2) 25 236 (33.5) 513 (1.9) 7173 (26.1)
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(disability pension or death)30—similar to the healthy 
worker effect.31 However, the number of person-years 
at risk (see online supplementary web appendix 1) 
shows that a substantial proportion of individuals re-
main in the working population despite fatal diseases.
2. Conditions with a moderate or small decrease in LTSA 
in the subsequent years (HR ratio between 0.46 and 
0.76, eg, substance abuse, inflammatory rheumatic dis-
ease, osteoarthritis in men and women and thyroid dis-
ease in women). Studies examining changes in LTSA 
of these conditions over time are scarce, but the results 
are in accordance with two previous studies of inflam-
matory rheumatic and thyroid diseases17 18 suggesting 
that the risks of LTSA remain elevated over time, but 
Table 3 Prevalence of chronic diseases at start of follow-up (entry) and end of follow-up (exit)
Variables
Women (n=75 319)
Men 
(n=27 427)
Entry Exit Entry Exit
n (%) n (%) n (%) n (%)
Physical chronic diseases
Chronic infection 17 (0.0) 174 (0.2) <5 (0.0) 98 (0.4)
  Cancer 186 (0.2) 3439 (4.6) 47 (0.2) 782 (2.9)
  Benign haematologic diseases including anaemia 47 (0.1) 702 (0.9) 8 (0.0) 125 (0.5)
  Diseases of the thyroid gland 337 (0.4) 3776 (5) 27 (0.1) 252 (0.9)
  Diabetes 148 (0.2) 1839 (2.4) 111 (0.4) 1227 (4.5)
  Other endocrine diseases and malnutrition 51 (0.1) 657 (0.9) 7 (0.0) 117 (0.4)
  Obesity 200 (0.3) 3264 (4.3) 31 (0.1) 405 (1.5)
  Neurological diseases 660 (0.9) 6759 (9) 98 (0.4) 1309 (4.8)
  Paraplegia and hemiplegia <5 (0.0) 25 (0.0) <5 (0.0) 12 (0.0)
  Eye diseases 109 (0.1) 1797 (2.4) 44 (0.2) 771 (2.8)
  Ear diseases 126 (0.2) 1865 (2.5) 64 (0.2) 978 (3.6)
  Hypertension 898 (1.2) 12 152 (16.1) 423 (1.5) 5217 (19.0)
  Ischaemic heart disease and heart failure 121 (0.2) 2083 (2.8) 118 (0.4) 1831 (6.7)
  Cardiac arrhythmia and valve disease 106 (0.1) 1484 (2) 52 (0.2) 735 (2.7)
  Stroke 46 (0.1) 837 (1.1) 20 (0.1) 435 (1.6)
  Vascular disease 49 (0.1) 690 (0.9) 19 (0.1) 380 (1.4)
  Chronic pulmonary disease including asthma 1209 (1.6) 7720 (10.2) 264 (1) 1899 (6.9)
  Inflammatory bowel disease 121 (0.2) 1541 (2.0) 40 (0.1) 501 (1.8)
  Diseases of the liver 26 (0.0) 499 (0.7) 17 (0.1) 243 (0.9)
  Diseases of the skin 1525 (2.0) 9991 (13.3) 365 (1.3) 3073 (11.2)
  Inflammatory rheumatic disease 182 (0.2) 2791 (3.7) 96 (0.4) 1239 (4.5)
  Degenerative rheumatic diseases including osteoarthritis 921 (1.2) 14 421 (19.1) 342 (1.2) 4890 (17.8)
  Osteoporosis 111 (0.1) 2497 (3.3) 9 (0.0) 186 (0.7)
  Chronic pain 3019 (4.0) 21409 (28.4) 944 (3.4) 6812 (24.8)
  Chronic pain* 227 (0.3) 3470 (4.6) 93 (0.3) 1321 (4.8)
  Diseases of the kidney 57 (0.1) 746 (1.0) 20 (0.1) 262 (1.0)
  Gynaecological diseases 48 (0.1) 816 (1.1)
Mental conditions
  Dementia 8 (0.0) 132 (0.2) <5 (0.0) 55 (0.2)
  Substance abuse 95 (0.1) 823 (1.1) 54 (0.2) 647 (2.4)
  Schizophrenia 6 (0.0) 154 (0.2) 6 (0.0) 60 (0.2)
  Depression and anxiety 792 (1.1) 9650 (12.8) 189 (0.7) 2012 (7.3)
  Eating disorders 34 (0.0) 106 (0.1) <5 (0.0) <5 (0.0)
  Personality disorders 72 (0.1) 545 (0.7) 11 (0.00) 129 (0.5)
 *Chronic pain classification only if no other chronic comorbidities. 
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some improvement in work capacity may be expected 
after the first year of diagnosis.
3. Conditions with little or no change in elevated risks of 
LTSA (HR ratio between 0.92 and 0.95: chronic pulmo-
nary disease, diabetes and skin disease in women) or 
increase in risks throughout the study period (HR ratio 
between 1.02 and 1.16 obesity and diabetes in men). 
Although previous literature documents that obesity 
is associated with LTSA,32 only one study examined 
changes in LTSA over time in diabetes. In accordance 
Table 4 Adjusted HRs of LTSA of chronic conditions within the first year and subsequent years of diagnosis
Condition
Women
Condition
Men
First year Subsequent years First year Subsequent years
HR 95% CI HR 95% CI
HR
ratio HR 95% CI HR 95% CI
HR
ratio
Cancer 7.05 6.56 to 7.57 1.46 1.36 to 1.57 0.21 Cancer 7.55 6.45 to 8.85 1.43 1.20 to 1.71 0.19
Stroke 4.75 4.02 to 5.61 1.36 1.18 to 1.58 0.29 Schizo 3.13 1.19 to 8.27 0.67 0.33 to 1.38 0.21
ParaHemi 5.53 2.06 to 4.90 2.02 1.15 to 3.55 0.37 Stroke 6.14 4.93 to 7.66 1.44 1.16 to 1.78 0.23
Osteoarthr 3.73 3.57 to 3.90 1.72 1.66 to 1.78 0.46 ParaHemi 6.58 1.25 to 34.56 1.90 0.49 to 7.29 0.29
Kidney 3.04 2.45 to 3.77 1.48 1.28 to 1.70 0.49 Heart 4.55 4.02 to 5.15 1.6 1.43 to 1.78 0.35
Gynaecol 2.59 2.14 to 3.14 1.30 1.16 to 1.45 0.50 Haemo 3.00 1.82 to 4.94 1.14 0.76 to 1.73 0.38
Eye 2.22 1.91 to 2.56 1.16 1.05 to 1.28 0.52 Infec 0.74 0.23 to 2.31 1.92 1.20 to 3.06 0.39
Haemo 2.05 1.56 to 2.70 1.17 1.02 to 1.35 0.57 Vascular 3.76 2.91 to 4.87 1.72 1.38 to 2.14 0.46
Inflarheum 2.89 2.58 to 3.23 1.68 1.56 to 1.80 0.58 Osteoarthr 3.55 3.26 to 3.88 1.63 1.52 to 1.74 0.46
Endo 2.06 1.57 to 2.71 1.22 1.03 to 1.45 0.59 Endo 3.00 1.78 to 5.05 1.38 0.95 to 2.01 0.46
Eating 2.35 0.96 to 5.74 1.39 0.96 to 2.01 0.59 Kidney 3.95 2.72 to 5.73 1.98 1.58 to 2.48 0.50
Personality 3.15 2.32 to 4.26 1.90 1.65 to 2.18 0.60 Arrhythm 3.07 2.44 to 3.86 1.56 1.31 to 1.85 0.51
Vascular 2.48 1.96 to 3.13 1.49 1.30 to 1.72 0.60 Neuro 3.00 2.50 to 3.60 1.67 1.48 to 1.88 0.56
Abuse 3.99 3.24 to 4.90 2.48 2.19 to 2.80 0.62 Osteoporosis 2.82 1.81 to 4.40 1.58 1.21 to 2.07 0.56
Arrhythm 2.10 1.79 to 2.47 1.31 1.19 to 1.45 0.62 Inflarheum 2.91 2.44 to 3.47 1.72 1.52 to 1.95 0.59
Schizo 2.38 1.26 to 4.48 1.49 1.06 to 2.10 0.63 Eye 2.30 1.80 to 3.15 1.38 1.17 to 1.62 0.60
Heart 2.60 2.29 to 2.95 1.67 1.53 to 1.83 0.64 Anxdep 3.45 2.97 to 4.00 2.17 1.98 to 2.38 0.63
Neuro 2.29 2.11 to 2.50 1.50 1.43 to 1.57 0.66 Personality 2.58 1.30 to 5.10 1.65 1.14 to 2.39 0.64
Dementia 1.87 1.00 to 3.47 1.23 0.83 to 1.83 0.66 Ear 1.81 1.41 to 2.32 1.15 0.98 to 1.34 0.64
Obesity 2.25 2.00 to 2.53 1.58 1.48 to 1.69 0.70 Dementia 2.74 1.19 to 6.30 1.79 1.79 to 3.70 0.65
Ear 1.85 1.57 to 2.18 1.31 1.19 to 1.43 0.71 Abuse 3.31 2.57 to 4.26 2.19 1.88 to 2.54 0.66
Bowel 1.95 1.67 to 2.31 1.39 1.26 to 1.54 0.71 Hyperten 2.22 2.00 to 2.47 1.58 1.47 to 1.62 0.71
Infec 1.48 0.79 to 2.78 1.06 0.76 to 1.48 0.72 Pulmonary 2.23 1.82 to 2.73 1.59 1.44 to 1.77 0.71
Anxdep 2.92 2.73 to 3.13 2.16 2.08 to 2.24 0.74 Pain 3.41 3.10 to 3.74 2.44 2.31 to 2.57 0.72
Osteoporosis 1.61 1.41 to 1.83 1.21 1.10 to 1.33 0.75 Bowel 2.37 1.78 to 3.17 1.76 1.44 to 2.15 0.74
Thyroid 1.54 1.36 to 1.75 1.21 1.14 to 1.28 0.79 Skin 1.80 1.51 to 2.14 1.37 1.27 to 1.48 0.76
Pain* 2.83 2.35 to 3.39 2.27 2.09 to 2.47 0.80 Liver 2.33 1.44 to 3.78 1.82 1.37 to 2.41 0.78
Pain 2.90 2.75 to 3.06 2.36 2.30 to 2.42 0.81 Pain* 3.15 2.21 to 4.48 2.48 2.11 to 2.91 0.79
Liver 1.95 1.42 to 2.68 1.64 1.37 to 1.97 0.84 Thyroid 1.59 0.97 to 2.61 1.30 0.99 to 1.71 0.82
Hyperten 1.71 1.60 to 1.83 1.45 1.40 to 1.51 0.85 Obesity 1.83 1.31 to 2.56 1.87 1.47 to 2.37 1.02
Pulmonary 1.69 1.53 to 1.87 1.55 1.49 to 1.61 0.92 Diabetes 1.57 1.24 to 1.98 1.82 1.60 to 2.06 1.16
Diabetes 1.60 1.35 to 1.91 1.49 1.36 to 1.63 0.93
Skin 1.40 1.27 to 1.54 1.33 1.28 to 1.38 0.95
Significant HR in bold (p<0.05); HR adjusted for immigrant status, highest attained education, marital status, calendar years and job-type; 
HR ratio of the subsequent years of diagnosis was divided with the first year: extreme decrease (HR ratio ≤0.25); strong decrease (>0.25 hour 
ratio ≤0.40); moderate decrease (>0.40 hour ratio ≤0.67); small decrease (>0.67 hour ratio ≤0.91); no change or increase (>0.91 hour 
ratio >1.00); HR ratio not valid: no marked colour.
*Chronic pain classification only if no other chronic comorbidities. 
Anxdep, depression and anxiety; Arrhythm, caridiac arrhythmia and valve disease; Endo, other endocrine diseases and malnutrition; 
Gynaecol, gynaecological diseases; Haemo, benign haematologic diseases including anaemia; Hyperten, hypertension; Infec, chronic 
infection; Inflarheum, inflammatory rheumatic disease; LTSA, long-term sickness absence; Neuro, neurological diseases; Osteoarthr, 
degenerative rheumatic diseases and osteoarthritis; ParaHemi, paraplegia and hemiplegia; Schizo, schizophrenia.
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with results of the present study, the study showed that 
the length of sickness absence spells due to diabetes 
increased over time.33 Future research should further 
examine whether these types of chronic conditions 
may be more prevalent in the work force than acute 
life-threatening conditions, because these chronic con-
ditions are characterised by a slow progression.
Some of the chronic conditions had no significantly 
elevated risks of LTSA (chronic infection, dementia, schiz-
ophrenia, eating disorders), which presumably reflect 
lack of statistical power because of few cases (table 1).
Our results showed pivotal gender differences: many 
conditions showed stronger association with LTSA for 
men than for women. Previous studies have indicated 
that women have more short-term sickness absence than 
men,10 34 but not necessarily more LTSA.12 13 The higher 
risks of LTSA for men may reflect the overall gender 
differences in health status and health behaviour: men 
have a higher risk of fatal conditions at an earlier age, for 
example, cardiovascular conditions35 and are less likely 
to seek help in the early stages of a condition, which can 
result in worse outcomes.36 37
We estimated HR by comparing the risk of LTSA in 
those with a particular condition with those without 
the condition without excluding participants with other 
comorbidities. Thus, the increased risk of LTSA seen in 
for example, individuals with hypertension may partly 
reflect the impact of comorbidities on hypertension. We 
did not attempt to evaluate the combined effect of multi-
morbidity in this study, since such multimorbidity may 
involve complex interaction effects that would be difficult 
to model for all the diseases. However, we evaluated the 
impact of chronic pain in two different ways: by either 
including or excluding individuals with other comorbid-
ities. The different approaches showed little difference 
between HR estimates and showed that the analyses that 
included comorbidities had higher statistical power.
Major strengths of the study were the study of a large 
cohort of >100 000 individuals in a prospective design with 
up to 17 years of follow-up. However, selection bias could 
threaten the internal validity as we had to exclude a large 
proportion of individuals because data were missing on 
key variables (16% of entire study population). Addition-
ally, our cohort was drawn from the general population 
but oversampled women and older age groups. We find 
it unlikely that this caused measurement errors because 
age was the underlying time variable in the analyses and 
results for men and women were analysed separately. 
However, assumptions about the prevalence of the condi-
tions cannot reliably be drawn from the present results.
Among other strengths were the validity of diagnosis 
and the availability of data from both the primary and 
secondary healthcare sector and the inclusion of a wide 
range of time-depending confounding variables. Misclas-
sification of LTSA was unlikely as it was connected to the 
reimbursement from the government, but participants 
with a chronic disease that did not require hospitalisation 
or treatment with disease-specific prescribed medication 
could have been misclassified. Although the number of 
people living of a fortune without collecting social bene-
fits may be small,29 they could have been misclassified as 
working in our study.
A full description of the social consequences of chronic 
disease includes disability pension and unemployment. 
However, dealing with these outcomes in addition to 
LTSA would have introduced too much complexity when 
comparing 32 chronic diseases. The Danish labour market 
can be characterised as a ‘flexi-curity’ system with a high 
transition between employment and unemployment, but 
a welfare system with easy access to social benefits.38 The 
risk of LTSA may differ according to different labour 
market systems of different countries and may limit the 
external validity to countries with a comparable degree of 
social security as the present study.
COnClusIOn
This study identified three different patterns of LTSA 
associated with the courses of 32 different chronic condi-
tions prevalent in the work force: (1) a strong decrease 
of LTSA from the first to subsequent years (eg, stroke 
and cancer), (2) a moderate or small decrease in LTSA 
from the first to subsequent years (eg, substance abuse, 
inflammatory rheumatic disease and thyroid disease in 
women), (3) conditions with no change in elevated risks 
of LTSA (chronic pulmonary disease, diabetes and skin 
disease in women) or increase in risks over time (obesity 
and diabetes in men). The result can help tailor strategies 
to manage the work disability associated with different 
chronic diseases over time. In addition to gender differ-
ences and disease duration, future studies should consider 
the influence of treatment adherence and co-existence of 
other diseases on work disability.
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